Introduction
The trade-off between increasing accuracy and faster result times for BD's Veritor Plus System presents a critical challenge in rapid COVID-19 testing. This scenario involves balancing the need for reliable test results with the urgency of quick turnaround times in a pandemic context. I'll analyze this trade-off by examining product details, stakeholder impacts, metrics, and experimental approaches to arrive at a strategic recommendation.
I'd like to outline my approach to ensure we're aligned on the key areas I'll be covering in my analysis.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Impacts our ability to gather real-world data and the urgency of improvements. Expected answer: Already deployed with significant market presence. Impact on approach: Would focus on iterative improvements rather than pre-launch optimizations.
Why it matters: Helps determine if we should prioritize accuracy or speed to maintain market position. Expected answer: We're among the top in accuracy but not significantly ahead. Impact on approach: Might lean towards maintaining accuracy while improving speed incrementally.
Why it matters: Different user groups may prioritize accuracy vs. speed differently. Expected answer: Mix of healthcare facilities and businesses, with growing individual consumer market. Impact on approach: Would tailor solutions to balance needs of professional and consumer users.
Why it matters: Identifies where to focus R&D efforts for speed improvements. Expected answer: Chemical reaction time is the main limiting factor. Impact on approach: Would explore innovations in reagents or testing methodology.
Why it matters: Determines the scope and timeline of potential improvements. Expected answer: Dedicated team with moderate resources available. Impact on approach: Would prioritize high-impact, resource-efficient improvements.
Practice similar questions
Subscribe to access the full answer